Assessment of Canadian provincial expenditures in depressed patients treated with venlafaxine XR versus SSRIs: the APEX Study

By Monfared A. A. Tahami   Han D.   Sheehy O.   Bexton B.   LeLorier J.  

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 83-94

Informa Healthcare

Access to resources Recommend Favorite

A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients

By Boulenger J.-P.   Huusom A. K. T.   Florea I.   Bækdal T.   Sarchiapone M.  

Current Medical Research and Opinion, Vol. 22, Iss. 7, 2006-07 ,pp. : 1331-1341

Informa Healthcare

Access to resources Recommend Favorite

Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases

By Wang Junling   Liu Xianchen   Mullins C. Daniel  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1303-1313

Informa Healthcare

Access to resources Recommend Favorite

Venlafaxine, but Not Mirtazapine Lowers Retinol-Binding Protein 4 Serum Concentrations in Nondiabetic Depressed Patients

By  

Psychotherapy and Psychosomatics, Vol. 79, Iss. 2, 2009-02 ,pp. : 123-125

Karger

Access to resources Recommend Favorite

Energy expenditure in ischemic stroke patients treated with moderate hypothermia

By Bardutzky Juergen   Georgiadis Dimitrios   Kollmar Rainer   Schwab Stefan  

Intensive Care Medicine, Vol. 30, Iss. 1, 2004-01 ,pp. : 151-154

Springer Publishing Company

Access to resources Recommend Favorite